COVID-19 vaccine boosters that target the Omicron virus variant may not be needed, according to a new study. Researchers with the National Institutes of Health (NIH), Moderna, and other institutions tested Moderna’s regular booster and Moderna’s Omicron-specific booster and found that both lead to “comparable and significant increases in neutralizing antibody responses against all VOC…
Omicron-Specific Vaccine Booster May Not Be Needed: Study
February 7, 2022
admin
Business & EconomyBusinesses in COVID-19CCP VirusEditor's PicksModernaOmicronPfizerVaccines & Safety
0 Comment
FDA, Doctors’ Group Reach Agreement on Production of Pfizer Vaccine Documents
A group seeking all the documents analyzed by U.S. drug regulators before approving Pfizer’s COVID-19 vaccine has reached an agreement with the government on how fast the documents will be produced. The Food and Drug Administration (FDA) must produce 10,000 pages by March 1 and another 10,000 pages by April 1 in response to the…
Few, If Any, Doses of Spikevax or Comirnaty Available in United States, Despite FDA Approvals
U.S. drug regulators have now approved the COVID-19 vaccines made by Pfizer and Moderna, but the approved versions of the vaccines don’t appear to be available yet in the United States. The Food and Drug Administration (FDA) approved Moderna’s jab on Jan. 31, about five months after it approved Pfizer’s shot. The approved vaccines are…
Facts Matter (Jan. 28): FDA Asks Judge To Delay First 55K Batch Of Vaccine Docs; Pfizer Lawyers Move to Intervene in Case
Sweden’s public health agency just put out a statement saying that they reject the idea of children under the age of 12 being forced to get the COVID vaccine. However, here in America, it’s a much different story, because not only has the Centers for Disease Control and Prevention approved the vaccine for everyone above…
Pfizer Moves to Intervene in High-Profile Case Dealing With COVID-19 Vaccine Safety Data
January 26, 2022
admin
AMERICABusiness & EconomyBusinesses in COVID-19CCP VirusCompaniesEditor's PicksPfizerUSUS NewsVaccineVaccines & Safety
0 Comment
Pfizer has asked a federal court to let it intervene in a high-profile case that has seen U.S. drug regulators try to slow-walk disclosure of data on Pfizer’s COVID-19 vaccine. Pfizer says it supports disclosing the data but wants to ensure that information exempt from disclosure under the Freedom of Information Act (FOIA) is not…
Pfizer Begins Study Evaluating COVID-19 Vaccine That Targets Omicron Variant
January 25, 2022
admin
BioNTechBrightBusiness & EconomyBusinesses in COVID-19CCP VirusEditor's PicksHealth NewsMind & BodyPfizerVaccines & Safety
0 Comment
Pfizer and its German partner on Tuesday launched a clinical study that will evaluate an updated version of their COVID-19 vaccine. The updated formulation targets Omicron, a variant of the CCP (Chinese Communist Party) virus. Omicron became dominant in the United States last month; the Pfizer-BioNTech vaccine has proven much less effective, especially against infection, versus the…
Researchers Concerned CCP Virus Will Develop Resistance to New Pfizer and Merck Pills
Researchers and U.S. health regulators are concerned that the CCP virus may quickly develop resistance to new antiviral treatments from Pfizer and Merck, prompting scientists to find new combinations that better protect against the virus. Molnupiravir, developed by Merck and Ridgeback Biotherapeutics, is intended for use at home by adults with mild to moderate COVID-19 who are…
Researchers Concerned CCP Virus Will Develop Resistance to New Pfizer, Merck Pills
Researchers and U.S. health regulators are concerned that the CCP (Chinese Communist Party) virus may quickly develop resistance to new antiviral treatments from Pfizer and Merck, prompting scientists to find new combinations that better protect against the pathogen that causes COVID-19. Molnupiravir, developed by Merck and Ridgeback Biotherapeutics, is intended for home use by adults with mild-to-moderate COVID-19…
Omicron Evades mRNA Booster Protection, South African Study Shows
January 20, 2022
admin
AfricaCCP VirusInternationalModernamRNAOmicronPfizerSouth AfricastudyThe LancetVaccines & SafetyWorld
0 Comment
The Omicron variant of the novel coronavirus is able to evade the protection bestowed by messenger RNA (mRNA) COVID-19 vaccines, such as those from Pfizer and Moderna, a South African study has found. A study published Tuesday in The Lancet examined some of the first documented breakthrough cases of the highly transmissible Omicron strain, which emerged…
Australia Approves Novavax COVID-19 Vaccine and New COVID Oral Drug Treatments
January 19, 2022
admin
AustraliaAustralian Technical Advisory Group on ImmunisationCCP VirusCOVID-19 vaccineGreg HuntInternationalLagevrioNovavaxoral pillsPaxlovidPfizerTherapeutic Goods AdministrationVaccines & SafetyWorld
0 Comment
The national drug regulator has given the green light to the Novavax vaccine, along with two oral treatments for patients currently suffering from COVID-19. The Therapeutic Goods Administration (TGA) on Thursday approved the Novavax vaccine, also called Nuvaxovid, for adults aged 18 years and over, making it the first protein-based COVID-19 vaccine in the country’s…
US News
RSS Error: A feed could not be found at `https://www.theepochtimes.com/c-us/feed`; the status code is `200` and content-type is `text/html; charset=utf-8`